Neuronuclear Assessment of Patients With Epilepsy

Seminars in Nuclear Medicine

Volumn 38, Issue 4, 2008, Pages 227-239

  Goffin, Karolien ^a   Dedeurwaerdere, Stefanie ^b   Van Laere, Koen ^a   Van Paesschen, Wim ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; ALPHA METHYLTRYPTOPHAN C 11; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CANNABINOID 1 RECEPTOR; CARFENTANIL C 11; CYSTEINE ETHYL ESTER TC 99M; DIPRENORPHINE C 11; DOPAMINE; FLUMAZENIL; FLUORODEOXYGLUCOSE F 18; GLUTAMIC ACID; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; HEXOKINASE; METHYLNALTRINDOLE C 11; MICONAZOLE; MU OPIATE RECEPTOR; NICOTINE; NICOTINIC RECEPTOR; OPIATE RECEPTOR; RADIOPHARMACEUTICAL AGENT; SEROTONIN 1A RECEPTOR; VIGABATRIN; WAY 100635 C 11;

CEREBROVASCULAR ACCIDENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPTIC FOCUS; EPILEPTOGENESIS; GLUCOSE METABOLISM; HUMAN; IMAGE PROCESSING; IMAGE RECONSTRUCTION; INTRACTABLE EPILEPSY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; REVIEW; SEIZURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE EPILEPSY; TUBEROUS SCLEROSIS;

BRAIN; EPILEPSY; HUMANS; IMAGE ENHANCEMENT; MOLECULAR PROBE TECHNIQUES; NUCLEAR MEDICINE; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 44249083952     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2008.02.004     Document Type: Review

References (89)

1. Fisher R.S., van Emde Boas W., Blume W., et al. Epileptic seizures and epilepsy: Definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46 (2005) 470-472
2. Hauser W.A., and Kurland L.T. The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia 16 (1975) 1-66
3. Hart Y.M., Sander J.W., Johnson A.L., et al. National general practice study of epilepsy: Recurrence after a first seizure. Lancet 336 (1990) 1271-1274
4. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22 (1981) 489-501
5. Li L.M., Fish D.R., Sisodiya S.M., et al. High resolution magnetic resonance imaging in adults with partial or secondary generalised epilepsy attending a tertiary referral unit. J Neurol Neurosurg Psychiatry 59 (1995) 384-387
6. Rosenow F., and Lüders H. Presurgical evaluation of epilepsy. Brain 124 (2001) 1683-1700
7. Elger C.E., Helmstaedter C., and Kurthen M. Chronic epilepsy and cognition. Lancet Neurol 3 (2004) 663-672
8. Wiebe S., Blume W.T., Girvin J.P., et al. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 345 (2001) 311-318
9. Cohen-Gadol A.A., Ozduman K., Bronen R.A., et al. Long-term outcome after epilepsy surgery for focal cortical dysplasia. J Neurosurg 101 (2004) 55-65
10. Sharp P.F., Smith F.W., Gemmell H.G., et al. Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: Human volunteer studies. J Nucl Med 27 (1986) 171-177
11. Vallabhajosula S., Zimmerman R.E., Picard M., et al. Technetium-99m ECD: A new brain imaging agent: in vivo kinetics and biodistribution studies in normal human subjects. J Nucl Med 30 (1989) 599-604
12. O'Brien T.J., So E.L., Mullan B.P., et al. Subtraction ictal SPECT co-registered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus. Neurology 50 (1998) 445-454
13. McNally K.A., Paige A.L., Varghese G., et al. Localizing value of ictal-interictal SPECT analyzed by SPM (ISAS). Epilepsia 46 (2005) 1450-1464
14. Maes F., Collignon A., Vandermeulen D., et al. Multimodality image registration by maximization of mutual information. IEEE Trans Med Imaging 16 (1997) 187-198
15. Dupont P., Van Paesschen W., Palmini A., et al. Ictal perfusion patterns associated with single MRI-visible focal dysplastic lesions: implications for the noninvasive delineation of the epileptogenic zone. Epilepsia 47 (2006) 1550-1557
16. Lee S.K., Lee S.Y., Yun C.H., et al. Ictal SPECT in neocortical epilepsies: Clinical usefulness and factors affecting the pattern of hyperperfusion. Neuroradiology 48 (2006) 678-684
17. Van Paesschen W., Dupont P., Sunaert S., et al. The use of SPECT and PET in routine clinical practice in epilepsy. Curr Opin Neurol 20 (2007) 194-202
18. Devous Sr. M.D., Thisted R.A., Morgan G.F., et al. SPECT brain imaging in epilepsy: A meta-analysis. J Nucl Med 39 (1998) 285-293
19. Bartolini A. Regional arm-brain mean transit time in the diagnostic evaluation of patients with cerebral vascular disease. Stroke 12 (1981) 241-245
20. Shin W.C., Hong S.B., Tae W.S., et al. Ictal hyperperfusion patterns according to the progression of temporal lobe seizures. Neurology 58 (2002) 373-380
21. Amorim B.J., Etchebehere E.C., Camargo E.E., et al. Statistical voxel-wise analysis of ictal SPECT reveals pattern of abnormal perfusion in patients with temporal lobe epilepsy. Arq Neuropsiquiatr 63 (2005) 977-983
22. Fukuda M., Masuda H., Honma J., et al. Ictal SPECT analyzed by three-dimensional stereotactic surface projection in frontal lobe epilepsy patients. Epilepsy Res 68 (2006) 95-102
23. Avery R.A., Spencer S.S., Spanaki M.V., et al. Effect of injection time on postictal SPET perfusion changes in medically refractory epilepsy. Eur J Nucl Med 26 (1999) 830-836
24. Cherry S.R. Multimodality in vivo imaging systems: Twice the power or double the trouble?. Annu Rev Biomed Eng 8 (2006) 35-62
25. Drzezga A., Arnold S., Minoshima S., et al. 18F-FDG PET studies in patients with extratemporal and temporal epilepsy: Evaluation of an observer-independent analysis. J Nucl Med 40 (1999) 737-746
26. Lin T.W., de Aburto M.A., Dahlbom M., et al. Predicting seizure-free status for temporal lobe epilepsy patients undergoing surgery: Prognostic value of quantifying maximal metabolic asymmetry extending over a specified proportion of the temporal lobe. J Nucl Med 48 (2007) 776-782
27. Gaillard W.D., Zeffiro T., Fazilat S., et al. Effect of valproate on cerebral metabolism and blood flow: An 18F-2-deoxyglucose and 15O water positron emission tomography study. Epilepsia 37 (1996) 515-521
28. Theodore W.H. Antiepileptic drugs and cerebral glucose metabolism. Epilepsia 29 suppl 2 (1988) S48-S55
29. Hunter G.J., Hamberg L.M., Alpert N.M., et al. Simplified measurement of deoxyglucose utilization rate. J Nucl Med 37 (1996) 950-955
30. Quarantelli M., Berkouk K., Prinster A., et al. Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. J Nucl Med 45 (2004) 192-201
31. Baete K., Nuyts J., Van Paesschen W., et al. Anatomical-based FDG-PET reconstruction for the detection of hypo-metabolic regions in epilepsy. IEEE Trans Med Imaging 23 (2004) 510-519
32. Baete K., Nuyts J., Van Laere K., et al. Evaluation of anatomy based reconstruction for partial volume correction in brain FDG-PET. Neuroimage 23 (2004) 305-317
33. Lee S.K., Lee S.Y., Kim K.K., et al. Surgical outcome and prognostic factors of cryptogenic neocortical epilepsy. Ann Neurol 58 (2005) 525-532
34. Breier J.I., Mullani N.A., Thomas A.B., et al. Effects of duration of epilepsy on the uncoupling of metabolism and blood flow in complex partial seizures. Neurology 48 (1997) 1047-1053
35. Casse R., Rowe C.C., Newton M., et al. Positron emission tomography and epilepsy. Mol Imaging Biol 4 (2002) 338-351
36. Park C.K., Kim S.K., Wang K.C., et al. Surgical outcome and prognostic factors of pediatric epilepsy caused by cortical dysplasia. Childs Nerv Syst 22 (2006) 586-592
37. Ollenberger G.P., Byrne A.J., Berlangieri S.U., et al. Assessment of the role of FDG PET in the diagnosis and management of children with refractory epilepsy. Eur J Nucl Med Mol Imaging 32 (2005) 1311-1316
38. Yun C.H., Lee S.K., Lee S.Y., et al. Prognostic factors in neocortical epilepsy surgery: Multivariate analysis. Epilepsia 47 (2006) 574-579
39. Choi J.Y., Kim S.J., Hong S.B., et al. Extratemporal hypometabolism on FDG PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy. Eur J Nucl Med Mol Imaging 30 (2003) 581-587
40. Henry T.R., Babb T.L., Engel Jr. J., et al. Hippocampal neuronal loss and regional hypometabolism in temporal lobe epilepsy. Ann Neurol 36 (1994) 925-927
41. Foldvary N., Lee N., Hanson M.W., et al. Correlation of hippocampal neuronal density and FDG-PET in mesial temporal lobe epilepsy. Epilepsia 40 (1999) 26-29
42. Cornford E.M., Gee M.N., Swartz B.E., et al. Dynamic [18F]fluorodeoxyglucose positron emission tomography and hypometabolic zones in seizures: Reduced capillary influx. Ann Neurol 43 (1998) 801-808
43. Nelissen N., Van Paesschen W., Baete K., et al. Correlations of interictal FDG-PET metabolism and ictal SPECT perfusion changes in human temporal lobe epilepsy with hippocampal sclerosis. Neuroimage 32 (2006) 684-695
44. McDonald C.R., Swartz B.E., Halgren E., et al. The relationship of regional frontal hypometabolism to executive function: a resting fluorodeoxyglucose PET study of patients with epilepsy and healthy controls. Epilepsy Behav 9 (2006) 58-67
45. Salzberg M., Taher T., Davie M., et al. Depression in temporal lobe epilepsy surgery patients: An FDG-PET study. Epilepsia 47 (2006) 2125-2130
46. Takaya S., Hanakawa T., Hashikawa K., et al. Prefrontal hypofunction in patients with intractable mesial temporal lobe epilepsy. Neurology 67 (2006) 1674-1676
47. Benedek K., Juhasz C., Chugani D.C., et al. Longitudinal changes in cortical glucose hypometabolism in children with intractable epilepsy. J Child Neurol 21 (2006) 26-31
48. Joo E.Y., Hong S.B., Han H.J., et al. Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy. Brain 128 (2005) 1802-1810
49. Van Paesschen W., Porke K., Fannes K., et al. Cognitive deficits during status epilepticus and time course of recovery: A case report. Epilepsia 48 (2007) 1979-1983
50. Treiman D.M. GABAergic mechanisms in epilepsy. Epilepsia 42 suppl 3 (2001) 8-12
51. Hammers A., Koepp M.J., Richardson M.P., et al. Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients. Brain 126 (2003) 1300-1318
52. Padma M.V., Simkins R., White P., et al. Clinical utility of 11C-flumazenil positron emission tomography in intractable temporal lobe epilepsy. Neurol India 52 (2004) 457-462
53. Koepp M.J., Richardson M.P., Brooks D.J., et al. Cerebral benzodiazepine receptors in hippocampal sclerosis. An objective in vivo analysis. Brain 119 (1996) 1677-1687
54. Koepp M.J., Hand K.S., Labbe C., et al. In vivo [11C]flumazenil-PET correlates with ex vivo [3H]flumazenil autoradiography in hippocampal sclerosis. Ann Neurol 43 (1998) 618-626
55. Hammers A., Koepp M.J., Brooks D.J., et al. Periventricular white matter flumazenil binding and postoperative outcome in hippocampal sclerosis. Epilepsia 46 (2005) 944-948
56. Hammers A., Panagoda P., Heckemann R.A., et al. [(11)C]Flumazenil PET in temporal lobe epilepsy: Do we need an arterial input function or kinetic modeling?. J Cereb Blood Flow Metab 28 (2008) 207-216
57. Bouvard S., Costes N., Bonnefoi F., et al. Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy: A [11C]flumazenil-PET study. Brain 128 (2005) 1330-1343
58. Chang Y.S., Jeong J.M., Yoon Y.H., et al. Biological properties of 2′-[18F]fluoroflumazenil for central benzodiazepine receptor imaging. Nucl Med Biol 32 (2005) 263-268
59. Tortella F.C., and Long J.B. Endogenous anticonvulsant substance in rat cerebrospinal fluid after a generalized seizure. Science 228 (1985) 1106-1108
60. Wagner J.J., Caudle R.M., Neumaier J.F., et al. Stimulation of endogenous opioid release displaces mu receptor binding in rat hippocampus. Neuroscience 37 (1990) 45-53
61. Frost J.J., Mayberg H.S., Fisher R.S., et al. Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. Ann Neurol 23 (1988) 231-237
62. Mayberg H.S., Sadzot B., Meltzer C.C., et al. Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography. Ann Neurol 30 (1991) 3-11
63. Madar I., Lesser R.P., Krauss G., et al. Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography. Ann Neurol 41 (1997) 358-367
64. Hammers A., Asselin M.C., Hinz R., et al. Upregulation of opioid receptor binding following spontaneous epileptic seizures. Brain 130 (2007) 1009-1016
65. Pasini A., Tortorella A., and Gale K. Anticonvulsant effect of intranigral fluoxetine. Brain Res 593 (1992) 287-290
66. Favale E., Rubino V., Mainardi P., et al. Anticonvulsant effect of fluoxetine in humans. Neurology 45 (1995) 1926-1927
67. Toczek M.T., Carson R.E., Lang L., et al. PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology 60 (2003) 749-756
68. Theodore W.H., Hasler G., Giovacchini G., et al. Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy. Epilepsia 48 (2007) 1526-1530
69. Giovacchini G., Toczek M.T., Bonwetsch R., et al. 5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction. J Nucl Med 46 (2005) 1128-1135
70. Ito S., Suhara T., Ito H., et al. Changes in central 5-HT(1A) receptor binding in mesial temporal epilepsy measured by positron emission tomography with [(11)C]WAY100635. Epilepsy Res 73 (2007) 111-118
71. Chugani D.C., Chugani H.T., Muzik O., et al. Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography. Ann Neurol 44 (1998) 858-866
72. Fedi M., Reutens D.C., Andermann F., et al. alpha-[11C]-Methyl-L-tryptophan PET identifies the epileptogenic tuber and correlates with interictal spike frequency. Epilepsy Res 52 (2003) 203-213
73. Kagawa K., Chugani D.C., Asano E., et al. Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-L-tryptophan positron emission tomography (PET). J Child Neurol 20 (2005) 429-438
74. Marini C., and Guerrini R. The role of the nicotinic acetylcholine receptors in sleep-related epilepsy. Biochem Pharmacol 74 (2007) 1308-1314
75. Picard F., Bruel D., Servent D., et al. Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. Brain 129 (2006) 2047-2060
76. Iversen L. Cannabis and the brain. Brain 126 (2003) 1252-1270
77. Wilson R.I., and Nicoll R.A. Endocannabinoid signaling in the brain. Science 296 (2002) 678-682
78. Marsicano G., Goodenough S., Monory K., et al. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302 (2003) 84-88
79. Ben Amar M. Cannabinoids in medicine: A review of their therapeutic potential. J Ethnopharmacol 105 (2006) 1-25
80. Wallace M.J., Wiley J.L., Martin B.R., et al. Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects. Eur J Pharmacol 428 (2001) 51-57
81. Wallace M.J., Martin B.R., and DeLorenzo R.J. Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur J Pharmacol 452 (2002) 295-301
82. Wallace M.J., Blair R.E., Falenski K.W., et al. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J Pharmacol Exp Ther 307 (2003) 129-137
83. Burns H.D., Van Laere K., Sanabria-Bohorquez S., et al. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Proc Natl Acad Sci U S A 104 (2007) 9800-9805
84. Pitkänen A., Kharatishvili I., Karhunen H., et al. Epileptogenesis in experimental models. Epilepsia 48 suppl 2 (2007) 13-20
85. Kornblum H.I., Araujo D.M., Annala A.J., et al. In vivo imaging of neuronal activation and plasticity in the rat brain by high resolution positron emission tomography (microPET). Nat Biotechnol 18 (2000) 655-660
86. Mirrione M.M., Schiffer W.K., Siddiq M., et al. PET imaging of glucose metabolism in a mouse model of temporal lobe epilepsy. Synapse 59 (2006) 119-121
87. Jupp B., Williams J., Binns D., et al. Imaging small animal models of epileptogenesis. Neurology Asia 12 suppl 1 (2007) 51-54
88. Dedeurwaerdere S., Jupp B., and O'Brien T.J. Positron emission tomography in basic epilepsy research: a view of the epileptic brain. Epilepsia 48 suppl 4 (2007) 56-64
89. Tipre D.N., Zoghbi S.S., Liow J.S., et al. PET imaging of brain 5-HT1A receptors in rat in vivo with 18F-FCWAY and improvement by successful inhibition of radioligand defluorination with miconazole. J Nucl Med 47 (2006) 345-353